To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults

NCT02369146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: UB-421

Sponsor

United BioPharma

Collaborators

[object Object]
[object Object]
[object Object]